The dream of biologics in uveitis.
Okada
Annabelle A
AA
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D001691:Biological Therapy; D006801:Humans; D000069285:Infliximab; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D011994:Recombinant Proteins; D014605:Uveitis / Q000628:therapy*
D000911:Antibodies, Monoclonal; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D000069285:Infliximab